US · Healthcare

Hypera SA (HYPMY)

Drug Manufacturers - Specialty & Generic

Hypera SA (HYPMY) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for HYPMY

P/E ratio
18.00

Hypera SA (HYPMY) — FAQ

What is HYPMY's P/E ratio?

The price-to-earnings (P/E) ratio for Hypera SA (HYPMY) is 18.00 (data as of 2026-05-23).

Does Hypera SA pay a dividend?

Dividend yield is not available in the current snapshot for Hypera SA (HYPMY). Check the MyAverix Finance app for the latest dividend data.

What sector is Hypera SA in?

Hypera SA (HYPMY) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is HYPMY listed on?

HYPMY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play